Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.49 |
| ▸ | EBP | Q15125 | 1/20 | 0.49 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.47 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19612463 | 1.00 | SIGMAR1 (0.49) | SIGMAR1EBPTMEM97CYP11B1CYP11B2 | |
| SCHEMBL19612474 | 0.86 | CYP11B1 (0.56) | SIGMAR1EBPTMEM97CYP11B1CYP11B2 | |
| SCHEMBL17912812 | 0.85 | NPC1 (0.47) | NPC1RAB9AMAOAMAOB | |
| SCHEMBL17912818 | 0.85 | NPC1 (0.47) | NPC1RAB9AMAOAMAOB | |
| SCHEMBL17912811 | 0.85 | RAB9A (0.49) | CYP11B1CYP11B2NPC1RAB9AMAOA | |
| SCHEMBL17912829 | 0.85 | RAB9A (0.49) | CYP11B1CYP11B2NPC1RAB9AMAOA | |
| SCHEMBL19612452 | 0.82 | NPC1 (0.47) | NPC1RAB9AMAOAMAOB | |
| SCHEMBL17912846 | 0.82 | NPC1 (0.47) | NPC1RAB9AMAOAMAOB | |
| SCHEMBL19612478 | 0.82 | ALOX5 (0.65) | NPC1RAB9APDGFRBPDGFRAMAOB | |
| SCHEMBL19612485 | 0.82 | ALOX5 (0.65) | NPC1RAB9APDGFRBPDGFRAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170336728-A1 | ULTRAVIOLET CURABLE LIQUID COMPOSITION, ULTRAVIOLET CURING INKJET INK, ULTRAVIOLET CURING WET ELECTROPHOTOGRAPHIC LIQUID DEVELOPER, ULTRAVIOLET CURING ELECTROSTATIC INKJET INK, AND IMAGE FORMING METHOD USING THEREOF | CANON KABUSHIKI KAISHA (JP) | 2017-11-23 | — | — | US | disclosed |